To see a fennec fox is to love the fennec fox. Their adorable little nose, framed with long black whiskers, large liquid dark ...

Fennec Pharmaceuticals shares were down after the company reported fourth-quarter results. The stock was recently down 10% to $6.20 and is down about 2% this year. Revenue declined to $7.93 ...

You can’t miss the fennec foxes big bat-like ears. These magnificent displays of environmental adaptation allow the fennec fox to pinpoint their prey, even when buried under the shifting sands.

Felix Ampomah; Analyst; Stephens, Inc. Good morning ladies and gentlemen, and welcome to Fennec Pharmaceuticals fourth quarter and full year 2024 earnings and corporate update conference call.

FENNEC PHARMACEUTICALS ($FENC) posted quarterly earnings results on Monday, March 10th. The company reported earnings of -$0.06 per share, missing estimates of $0.17 ...

Over-Year, and Generated PEDMARK ® Q4 2024 Net Product Sales of $7.9 Million ~ ~ Delivered Q4 2024 EBITDA Loss of $0.6 Million and Company Has $26.6 Million in Cash, Cash Equivalents and Short-Term ...

Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Q4 2024 Earnings Call Transcript March 10, 2025 Fennec Pharmaceuticals Inc. misses ...

Early Repayment of $13 Million of the Company’s Approximately $32 Million Outstanding Convertible Debt Facility: In December 2024, Fennec announced the early partial repayment of a significant ...